Etiometry has received the US FDA approval for its IVCO2 Index\u2122 for use with neonatal ICU patients under 2kg, who are especially vulnerable to the effects of hypercapnia. <\/p>\n\n\n\n
Etiometry\u2019s IVCO2 Index\u2122 is a game changer in critical care, seamlessly integrating multiple data sources to provide an individualized assessment for ventilation-perfusion mismatch and detect the likelihood a patient will have a PaCO2 of greater than 50 mmHg in mechanically ventilated patients. It has been specifically designed to overcome the challenges of existing conventional monitoring, such as arterial blood gas testing and transcutaneous monitoring for tiny premature newborns.<\/p>\n\n\n\n
\u201cThe IVCO2 Index\u2122 is a first-of-its-kind algorithm that increases the ability to detect hypercapnia risk without needing additional hardware attached to these fragile patients,\u201d said Dimitar Baronov, CTO of Etiometry. \u201cIt allows clinicians to prioritize care for patients who need it most.\u201d<\/p>\n\n\n\n
Many NICU patients require ventilatory support and their conditions can change quickly. Vigilant monitoring for hypercapnia is critical for maximizing neurodevelopmental outcomes and preventing complications. Digital monitoring illuminates the patient’s condition between routine blood gas testing, adding another layer of protection to prevent oversights that may lead to poor outcomes.<\/p>\n\n\n\n
\u201cOur proprietary algorithm\u2019s accurate and continuous monitoring for hypercapnia will enable the expansion of improved outcomes achieved by Etiometry partners within cardiac ICUs and PICUs into the NICU environment,\u201d said Shane Cooke, CEO of Etiometry.<\/p>\n\n\n\n
Etiometry will showcase all of its risk indices and ways the platform helps improve outcomes by informing escalation and de-escalation decision-making at the upcoming World Congress of Pediatric Cardiology and Cardiac Surgery in Washington, D.C. later this month. Etiometry also supported the submission of five abstracts for this event.<\/p>\n","protected":false},"excerpt":{"rendered":"
Etiometry\u2019s IVCO2 Index\u2122 is now available for continuous non-invasive NICU ventilation monitoring for optimal outcomes without additional devices<\/p>\n","protected":false},"author":2,"featured_media":23171,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[7,681,683,25],"tags":[687],"class_list":["post-23170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-care-therapy","category-digital-health","category-products-technologies","tag-fda"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/23170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=23170"}],"version-history":[{"count":2,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/23170\/revisions"}],"predecessor-version":[{"id":23173,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/23170\/revisions\/23173"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/23171"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=23170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=23170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=23170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}